Book, Rezende Obstetrícia 13/16[LS]

Classic that has contributed to the training of several generations of students and health professionals, Rezende | Obstetrícia continues to provide the best and most complete content in the area in a completely redesigned edition, with a bolder graphic design, revised, expanded and fully updated content. Among the main features that complement the text and facilitate learning are detailed tables, exquisite images and illustrations, as well as carefully planned algorithms. Main highlights of this edition:• Epidemiological alert made by PAHO and WHO in December 2015 regarding the rate of microcephaly in Brazil, which, in 14 states, increased 20 times, from 2010 to 2015, and WHO decree for global public health emergency for Zika virus (ZIKV) and microcephaly in February 2016• Association of microcephaly in pregnancy with congenital infections classic diseases known as TORCH – Toxoplasmosis, Others (syphilis, varicella-zoster, parvovirus B19), Rubella, Cytomegalovirus and Herpes simplex – transforms the acronym into TORCHZ• Addressing the two biggest obstetric problems, which continue to be preterm birth and preterm -eclampsia/eclampsia• Indication of universal ultrasound of the cervix at the time of morphological examination between 20 and 24 weeks to prevent preterm birth, with vaginal progesterone• Screening for pre-eclampsia/eclampsia in the first trimester of pregnancy and identification of pregnant women with high -risk, for prevention with low-dose acetylsalicylic acid, which must be started before 12 weeks• Recommendation from the HAPO-2008 study due to the increased incidence of gestational diabetes mellitus: the diagnosis must be made in two stages – fasting blood glucose at first prenatal consultation and 75 g oral glucose tolerance test between 24 and 28 weeks of gestation• Revolution in prenatal diagnosis using non-invasive prenatal testing (NIPT) on maternal blood (cell-free DNA). The three pillars of prenatal diagnosis currently are NIPT at 10 weeks, first trimester ultrasound (11-13 weeks), and invasive testing (chorionic villus sampling and amniocentesis).